CNR Institutional Research Information System

SCIANDRA, FRANCESCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.882
NA - Nord America 1.145
EU - Europa 1.127
SA - Sud America 398
AF - Africa 37
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.592
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.089
SG - Singapore 786
RU - Federazione Russa 656
CN - Cina 404
BR - Brasile 313
VN - Vietnam 231
HK - Hong Kong 204
FR - Francia 137
IT - Italia 124
KR - Corea 68
GB - Regno Unito 48
JP - Giappone 48
AR - Argentina 40
DE - Germania 38
NL - Olanda 34
IN - India 32
CA - Canada 29
BD - Bangladesh 20
FI - Finlandia 20
ID - Indonesia 17
EC - Ecuador 15
ZA - Sudafrica 15
IL - Israele 11
MX - Messico 11
TR - Turchia 11
CO - Colombia 8
IQ - Iraq 8
PL - Polonia 8
BE - Belgio 7
LT - Lituania 7
PK - Pakistan 7
UA - Ucraina 7
AT - Austria 6
ES - Italia 6
SA - Arabia Saudita 6
VE - Venezuela 6
AZ - Azerbaigian 5
CL - Cile 5
EG - Egitto 5
IE - Irlanda 4
OM - Oman 4
PA - Panama 4
PY - Paraguay 4
UY - Uruguay 4
BO - Bolivia 3
JO - Giordania 3
RO - Romania 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
TN - Tunisia 3
UZ - Uzbekistan 3
AL - Albania 2
BB - Barbados 2
CH - Svizzera 2
ET - Etiopia 2
HN - Honduras 2
HR - Croazia 2
JM - Giamaica 2
KE - Kenya 2
KG - Kirghizistan 2
LB - Libano 2
MA - Marocco 2
MD - Moldavia 2
NI - Nicaragua 2
PH - Filippine 2
PT - Portogallo 2
SE - Svezia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
BS - Bahamas 1
CY - Cipro 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DZ - Algeria 1
EE - Estonia 1
GA - Gabon 1
GR - Grecia 1
GT - Guatemala 1
HU - Ungheria 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MK - Macedonia 1
MR - Mauritania 1
MY - Malesia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
SY - Repubblica araba siriana 1
TM - Turkmenistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZM - Zambia 1
Totale 4.592
Salva come PNG Salva come JPEG
Città #
Santa Clara 499
Singapore 457
Hong Kong 202
Hefei 163
San Jose 140
Lauterbourg 94
Beijing 91
Ho Chi Minh City 79
Seoul 68
Ashburn 57
Los Angeles 55
Hanoi 53
Rome 47
Tokyo 38
Dallas 37
Milan 37
São Paulo 26
Frankfurt am Main 20
New York 18
Rio de Janeiro 15
Haiphong 14
Orem 14
London 11
Chennai 10
Lappeenranta 10
Buffalo 9
Da Nang 9
Helsinki 9
Johannesburg 9
Porto Alegre 9
Toronto 9
Belo Horizonte 8
Minamishinagawa 8
Brussels 7
Phoenix 7
Bengaluru 6
Brasília 6
Buenos Aires 6
Houston 6
Baghdad 5
Bexley 5
Bristol 5
Campinas 5
Can Tho 5
Curitiba 5
Dhaka 5
Guayaquil 5
Hải Dương 5
Lahore 5
Manchester 5
Montreal 5
Aracaju 4
Baku 4
Brooklyn 4
Carapicuíba 4
Cleveland 4
Council Bluffs 4
Dublin 4
Düsseldorf 4
Lấp Vò 4
Ninh Bình 4
Nuremberg 4
Portsmouth 4
Roubaix 4
São José do Rio Preto 4
Vienna 4
Warsaw 4
Acalanes Ridge 3
Amman 3
Anápolis 3
Bergamo 3
Blumenau 3
Bogotá 3
Boston 3
Bình An 3
Bình Dương Province 3
Cairo 3
Cao Lanh 3
Chicago 3
Dakar 3
Didcot 3
Durban 3
Fortaleza 3
Jakarta 3
Jeddah 3
Joinville 3
Kyiv 3
Las Vegas 3
Marília 3
Montevideo 3
Mumbai 3
Panama City 3
Riyadh 3
San Francisco 3
Santo André 3
Seeb 3
Tashkent 3
Thái Nguyên 3
Treviso 3
Vitória da Conquista 3
Totale 2.586
Salva come PNG Salva come JPEG
Nome #
Analysis at the molecular level of the interaction between ±-dystroglycan and ²-dystroglycan and assessment of its implication for skeletal muscle physiopathology 720
Verbascoside Elicits Its Beneficial Effects by Enhancing Mitochondrial Spare Respiratory Capacity and the Nrf2/HO-1 Mediated Antioxidant System in a Murine Skeletal Muscle Cell Line 91
Analysis of the GFP-labelled β-dystroglycan interactome in HEK-293 transfected cells reveals novel intracellular networks 89
Molecular mechanisms underlying muscle wasting in huntington's disease 87
The missense mutation C667F in murine β-dystroglycan causes embryonic lethality, myopathy and blood-brain barrier destabilization 77
Activation of muscle-specific receptor tyrosine kinase and binding to dystroglycan are regulated by alternative mRNA splicing of agrin 73
A new monoclonal antibody DAG-6F4 against human alpha-dystroglycan reveals reduced core portein in some, but not all, dystroglycanopathy patients 68
Structural model of domain 1 of the alfa-dystroglycan glycosylating enzyme LARGE 68
3D Graphene Scaffolds for Skeletal Muscle Regeneration: Future Perspectives 63
Discovery of 4-benzyloxy and 4-(2-phenylethoxy) chalcone fibrate hybrids as novel PPARα agonists with anti-hyperlipidemic and antioxidant activities: Design, synthesis and in vitro/in vivo biological evaluation 62
Identification and Modeling of a GT-A Fold in the α-Dystroglycan Glycosylating Enzyme LARGE1 61
Multifunctional scaffolds for biomedical applications: Crafting versatile solutions with polycaprolactone enriched by graphene oxide 61
3D-printed graphene polylactic acid devices resistant to SARS-CoV-2: Sunlight-mediated sterilization of additive manufactured objects 60
Identification of the beta-dystroglycan binding epitope within the C-terminal region of alpha-dystroglycan. 56
Molecular and structural basis of dystroglycanopathies 54
A primary dystroglycanopathy causing muscle-eye-brain disease with multicystic leukodystrophy: from cellular and biochemical analysis to a mouse model 53
Identification and Modeling of a GT-A Fold in the ?-Dystroglycan Glycosylating Enzyme LARGE1 51
Synchrotron Radiation as a tool for the investigation of the structural basis of primary dystroglycanopathies. 50
A dystroglycan mutation (p.Cys667Phe) associated to muscle-eye-brain disease with multicystic leucodystrophy results in ER-retention of the mutant protein. 50
Alpha-dystroglycan is a potential target of matrix metalloproteinase MMP-2 48
The molecular basis of alpha-Dystroglycan hypoglycosylation: a crystallographic and SAXS study 48
Advanced approaches in skin wound healing - a review on the multifunctional properties of MXenes in therapy and sensing 48
Punicalagin Protects Human Retinal Pigment Epithelium Cells From Ultraviolet Radiation-Induced Oxidative Damage by Activating Nrf2/HO-1 Signaling Pathway and Reducing Apoptosis 47
From adhesion complex to signaling hub: the dual role of dystroglycan 47
Structural flexibility of human ?lpha-dystroglycan 46
Perturbation of the alpha/beta-dystroglycan interaction: consequences for skeletal muscle stability 45
The effect of the pathological V72I, D109N and T190M missense mutations on the molecular structure of ?-dystroglycan 45
Structural flexibility of human alpha-dystroglycan 45
The enzymatic processing of ?-dystroglycan by MMP-2 is controlled by two anchoring sites distinct from the active site 44
The enzymatic processing of ?-dystroglycan by MMP-2 is controller by two anchoring sites distinct from the active site 44
Genetic Engineering of Dystroglycan in Animal Models of Muscular Dystrophy. 43
Extracellular Vesicle Molecular Profiling for Diagnostic Purposes: An Application of Phage Display Technology 42
Live optical super-resolution microcospy applied to the characterization of maturation, localization and trafficking of defective dystroglycan mutants 42
BPS2025 - Novel 3D-printed wound healing transwell system for reproducible analysis of skin dressing 42
optical nanoscopy applied to the characterization of maturation and localization of defective dystroglycan mutants 41
Concerted mutation of Phe residues belonging to the beta-dystroglycan ectodomain strongly inhibits the interaction with alpha-dystroglycan in vitro 40
Insights from molecular dynamics simulations: Structural basis for the V567D mutation-induced instability of zebrafish alpha-dystroglycan and comparison with the murine model 40
Structural model of domain 1 of the alfa-dystroglycan glycosylating enzyme LARGE 40
Analisi strutturale e funzionale dei domini del distroglicano: ruolo per la stabilità del muscolo e aspetti fisiopatologici 40
MicroRNA from human peripheral blood leukocytes and cardiovascular diseases 39
?-Dystroglycan hypoglycosylation affects cell migration by influencing ?-dystroglycan membrane clustering and filopodia length: A musticale confocal microscopi analysis 38
Identification of the MMP-9 cleavage site on the recombinant b-dystroglycan ectodomain 38
Alpha-Dystroglycan is a potential target of matrix metalloproteinase MMP-2 37
A second Ig-like domain identified in dystroglycan by molecular modelling and dynamics 37
Novel thiazolidin-4-one benzenesulfonamide hybrids as PPARγ agonists: Design, synthesis and in vivo anti-diabetic evaluation 36
Design and synthesis of novel quinazolinone-based fibrates as PPARα agonists with antihyperlipidemic activity 36
Evaluating the role of the dystroglycan alpha/beta interface in human muscular dystrophies 35
Immunological dissection of the human dystroglycan complex 35
The Multiple Affinities of alpha-Dystroglycan 34
Modeling and molecular dynamics of alpha-dystroglycan's C-terminus reveals the presence of an Ig-like domain encompassing its beta-dystroglycan binding epitope 34
Evaluating the role of the dystroglycan alpha/beta interface in human muscular dystrophies 33
The structure of the T190M mutant of murine ?-dystroglycan at high resolution: insight into the molecular basis of a primary dystroglycanopathy 33
Mutagenesis at the alpha-beta interface impairs the cleavage of the dystroglycan precursor 33
±- and ²-dystroglycan: evaluation of processing and targeting through multiple fluorescent tagging 33
Enzymatic processing by MMP-2 and MMP-9 of wild-type and mutated mouse ss-dystroglycan 33
First molecular characterization and immunolocalization of keratoepithelin in adult human skeletal muscle 33
The Structure of the T190M Mutant of Murine alpha-Dystroglycan at High Resolution: Insight into the Molecular Basis of a Primary Dystroglycanopathy 32
Il Distroglicano, un recettore coinvolto nelle distrofie muscolari: dalla biochimica cellulare ad un modello murino. 32
Dystroglycan is associated to the disulfide isomerase ERp57 32
Analysis of dystroglycan in human patients affected by neuromuscular disorders.Analysis of dystroglycan in human patients affected by neuromuscular disorders 31
Structural characterization by NMR of the natively unfolded extracellular domain of beta-dystroglycan: toward the identification of the binding epitope for alpha-dystroglycan. 30
Enzymatic Processing of beta-Dystroglycan Recombinant Ectodomain By MMP-9: Idendification of the Main Cleavage Site 30
Mutagenesis of the ±- and ²- dystroglycan interface 30
An immunological analysis of dystroglycan subunits: lessons learned from a small cohort of non-congenital dystrophic patients. 30
The molecular basis of ?-dystroglycan hypoglycosylation: a crystallographic and SAXS study 30
Plasticity of secondary structure in the N-terminal region of beta-dystroglycan. 29
Evaluation of the effect of a floxed Neo cassette within the dystroglycan (Dag1) gene 29
A synthetic peptide corresponding to the 550-585 region of alpha-dystroglycan binds beta-dystroglycan as revealed by NMR spectroscopy. 29
Assessing the role of the ±/²-dystroglycan interface for the processing and maturation of the dystroglycan precursor 29
Dystroglycan and muscular dystrophies related to the dystrophin-glycoprotein complex 28
Dystroglycan: a possible mediator for reducing congenital muscular dystrophy? 28
Structural characterization by NMR of the natively unfolded extracellular domain of beta-dystroglycan: toward the identification of the binding epitope for alpha-dystroglycan 28
Proteasome Activity Is Affected by Fluctuations in Insulin-Degrading Enzyme Distribution 28
The molecular basis of alpha-dystroglycan hypoglycosylation: a crystallographic and SAXS study 28
The human keratoepithelin FAS1-4 domain as a model for the study of protein misfolding and amyloidogenesis: recombinant expression and preliminary characterisation 27
alpha-Dystroglycan does not play a major pathogenic role in autosomal recessive hereditary inclusion-body myopathy 27
Quantification, 2DE analysis and identification of enriched glycosylated proteins from mouse muscles: Difficulties and alternatives 27
Structural and functional analysis of the N-terminal extracellular region of beta-dystroglycan. 27
FRAP analysis of dystroglycan, a membrane receptor involved in congenital muscular dystrophies 26
Insertion of a myc-tag within alpha-dystroglycan domains improves its biochemical and microscopic detection 26
Role of gelatinases in pathological and physiological processes involving the dystrophin-glycoprotein complex 26
Dystroglycan and muscular dystrophies related to the dystrophin-glycoprotein complex. 26
Immunodetection of partially glycosylated isoforms of alpha-dystroglycan by a new monoclonal antibody against its beta-dystroglycan-binding epitope 26
Insights into the structure of the N-terminal region of alpha-dystroglycan: a concerted crystallographic and SAXS study 25
First genetic analysis of lattice corneal dystrophy type I in a family from Bulgaria 25
Towards a reliable modeling approach for all dystroglycan domains 25
The Structure of the T190M Mutant of Murine alpha-Dystroglycan at High Resolution: Insight into the Molecular Basis of a Primary Dystroglycanopathy 24
Biochemical and cellular analysis of the dystroglycan alpha/beta interface 24
A new monoclonal antibody DAG-6F4 against human alpha-dystroglycan reveals reduced core protein in some, but not all, dystroglycanopathy patients 24
Analysis at the molecular level of the interaction between alfa-dystroglycan and beta-dystroglycan 24
The structure of the N-terminal region of murine skeletal muscle alpha-dystroglycan discloses a modular architecture 24
Biochemical analysis of dystroglycan mutants involved in muscular dystrophies 23
Insights into the structure of the N-terminal region of ?-dystroglycan: a concerted crystallographic and SAXS study 23
Identification of keratoepithelin in human skeletal muscle 23
Insertion of a myc-tag within ?-dystroglycan domains improves its biochemical and microscopic detection 23
Structural and functional aspects of dystroglycan: towards the elucidation of its pathophysiological role 22
Live cell optical super-resolution microscopy of dystroglycan mutants as a model for dystroglycanopathies in multiple cell lines 22
Immunostaining of the sarcolemma with a new monoclonal antibody against alpha-dystroglycan core and its relevance to diagnosis 22
Alpha Dystroglycan monoclonal antibodies 22
MicroRNAs in human blood leukocytes and coronary angioplasy 21
Totale 4.535
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.915
article - articoli 7.789
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 105
Totale 20.809
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202418 0 0 0 0 0 0 0 0 6 6 4 2
2024/20251.706 1 6 115 48 393 217 16 117 51 66 390 286
2025/20262.954 114 232 283 375 374 125 318 116 805 106 106 0
Totale 4.678